Literature DB >> 12220550

IL-2 and autoimmune disease.

Anneliese Schimpl1, Ingolf Berberich, Burkhardt Kneitz, Susanne Krämer, Brigitte Santner-Nanan, Sabine Wagner, Martina Wolf, Thomas Hünig.   

Abstract

A decade after the first description of IL-2-deficient mice, the redundancy of IL-2 as a T cell growth factor is well accepted and the focus of research has shifted to the unexpected multiorgan autoimmunity and inflammation observed in mice lacking components of the IL-2/IL-2R system. So far, a set of defects at the levels of repertoire selection, the generation of suppressive regulatory T cells, T cell homing and clonal contraction via activation induced cell death (AICD) have been documented. We propose that these individual defects jointly contribute to the severe disturbance of T cell homeostasis and self-tolerance underlying the immunopathology of the IL-2 deficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220550     DOI: 10.1016/s1359-6101(02)00022-9

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  29 in total

Review 1.  Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity.

Authors:  Francesca Granucci; Ivan Zanoni; Sonia Feau; Paola Ricciardi-Castagnoli
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 2.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

3.  The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression.

Authors:  Michael M Reily; Carlos Pantoja; Xiaoyu Hu; Yurii Chinenov; Inez Rogatsky
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

4.  Insufficient (sub-native) helix content in soluble/solid aggregates of recombinant and engineered forms of IL-2 throws light on how aggregated IL-2 is biologically active.

Authors:  Uzma Fatima; Balvinder Singh; Karthikeyan Subramanian; Purnananda Guptasarma
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

5.  BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes.

Authors:  Valeriu B Cismasiu; Sailaja Ghanta; Javier Duque; Diana I Albu; Hong-Mei Chen; Rohini Kasturi; Dorina Avram
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

6.  Maternal vitamin D deficiency during pregnancy affects expression of adipogenic-regulating genes peroxisome proliferator-activated receptor gamma (PPARγ) and vitamin D receptor (VDR) in lean male mice offspring.

Authors:  Anthony M Belenchia; Karen L Jones; Matthew Will; David Q Beversdorf; Victoria Vieira-Potter; Cheryl S Rosenfeld; Catherine A Peterson
Journal:  Eur J Nutr       Date:  2016-12-21       Impact factor: 5.614

Review 7.  Why do T cells express the vitamin D receptor?

Authors:  Margherita T Cantorna
Journal:  Ann N Y Acad Sci       Date:  2010-11-29       Impact factor: 5.691

Review 8.  Rethinking Communication in the Immune System: The Quorum Sensing Concept.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; Martin Guilliams; György Haskó
Journal:  Trends Immunol       Date:  2019-01-02       Impact factor: 16.687

9.  Estrogenic activity of coumestrol, DDT, and TCDD in human cervical cancer cells.

Authors:  Kenneth Ndebele; Barbara Graham; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2010-05-04       Impact factor: 3.390

10.  BCL6 controls Th9 cell development by repressing Il9 transcription.

Authors:  Ribal Bassil; William Orent; Marta Olah; Ahmed T Kurdi; Michael Frangieh; Thomas Buttrick; Samia J Khoury; Wassim Elyaman
Journal:  J Immunol       Date:  2014-05-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.